By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Lipocine Inc. 

675 Arapeen Drive
Suite 202
Salt Lake City  Utah  84108  U.S.A.
Phone: 801-994-7383 Fax:


Company News
Lipocine (LPCN) Completes Post Action Meeting With FDA For LPCN 1021 New Drug Application 10/17/2016 7:13:25 AM
Clarus Therapeutics Provides Update On Patent Infringement Lawsuit Against Lipocine (LPCN)'s Oral Product For Testosterone Replacement Therapy 10/13/2016 8:15:26 AM
Lipocine (LPCN) Wins Dismissal Of Patent Infringement Lawsuit Related To LPCN 1021 10/10/2016 9:02:53 AM
Lipocine (LPCN) Announces Positive Top-Line Phase IIb Study Results For LPCN 1111, A Next Generation Oral Testosterone Replacement Therapy 9/26/2016 7:48:48 AM
Lipocine (LPCN) To Present At 2016 Ladenburg Thalmann Healthcare Conference 9/20/2016 8:17:42 AM
Lipocine (LPCN) Announces Financial And Operational Results For The Second Quarter Of 2016 8/9/2016 10:45:27 AM
Lipocine (LPCN) To Present At 36th Annual Canaccord Genuity Growth Conference 8/4/2016 8:41:46 AM
5 Biotech Stocks on the Brink of Breaking Out 7/25/2016 6:08:30 AM
Lipocine (LPCN) Shares Slump as FDA Does Not Approve NDA for Testosterone Drug LPCN 1021 6/29/2016 8:24:33 AM
Upcoming PDUFA And ANDA Approval Dates Could Catalyze Innovus Pharma And Lipocine Inc. (LPCN) 5/17/2016 12:28:01 PM